Form 4: Doximity Director Sells Shares Under 10b5-1 Plan

Doximity Director Timothy S. Cabral converted and sold 10,000 shares of Class A Common Stock for $50 per share, following an option exercise, under a pre-arranged trading plan.

Summary

• Timothy S. Cabral, a Director of Doximity, Inc., engaged in several transactions on November 21, 2025.
• Exercised a stock option to acquire 10,000 shares of Class B Common Stock at an exercise price of $2.21 per share.
• Converted 10,000 shares of Class B Common Stock into 10,000 shares of Class A Common Stock.
• Sold 10,000 shares of Class A Common Stock at a price of $50 per share.
• The sale was executed automatically under a Rule 10b5-1 trading plan adopted on February 13, 2025.
• Following these transactions, Cabral beneficially owns 3,221 shares of Class A Common Stock and 333,500 shares of Class B Common Stock directly.

Sentiment

Score: 5

Explanation: Neutral. The filing reports a planned insider transaction (sale under 10b5-1 plan) which is a routine event for executives managing their personal finances and equity holdings. It doesn't inherently signal positive or negative company performance.

Positives

• The transactions were pre-arranged under a Rule 10b5-1 trading plan, indicating a planned sale rather than an immediate reaction to new information.

Negatives

• A director selling shares, even under a pre-arranged plan, could be perceived negatively by some investors.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports insider transactions.

Industry Context

This Form 4 filing reports an insider transaction and does not contain information relevant to broader industry trends or competitive analysis. It reflects a director's personal equity management strategy.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4) and does not contain information that allows for a comparison of Doximity's operational or financial results to industry benchmarks or specific comparable companies/projects. The transaction itself is a common occurrence for executives managing their equity holdings.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even if planned, could be viewed with slight caution, but the amount is relatively small compared to total outstanding shares. The existence of a 10b5-1 plan mitigates concerns about opportunistic selling.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider sale by a director under a Rule 10b5-1 plan. Such transactions are typically for personal financial management and do not reflect a change in the company's fundamentals or future prospects. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Sale, Director Transaction, 10b5-1 Plan, Equity Conversion, Stock Option Exercise